Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -87,887 | -35,583 | -149,291 | -97,505 | -54,923 |
| Depreciation Amortization | 1,896 | 1,030 | 3,668 | 2,590 | 1,633 |
| Accounts payable and accrued liabilities | -4,724 | -6,268 | 13,702 | 7,675 | 2,842 |
| Other Working Capital | -5,380 | -21,745 | 9,256 | -8,081 | -19,129 |
| Other Operating Activity | 14,447 | 11,827 | 3,102 | 3,826 | 5,034 |
| Operating Cash Flow | $-81,648 | $-50,739 | $-119,563 | $-91,495 | $-64,543 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -89,530 | -55,327 | -236,721 | -208,207 | -156,562 |
| PPE Investments | -1,662 | -1,401 | -3,618 | -1,628 | -747 |
| Purchase Of Investment | 104,740 | 52,077 | 98,010 | 72,178 | 22,500 |
| Sale Of Investment | 2,759 | 2,515 | 4,437 | 0 | 0 |
| Investing Cash Flow | $16,307 | $-2,136 | $-137,892 | $-137,657 | $-134,809 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 117 | 18 | 157,821 | 157,732 | 157,275 |
| Financing Cash Flow | $117 | $18 | $157,821 | $157,732 | $157,275 |
| Beginning Cash Position | 203,519 | 203,519 | 303,153 | 303,153 | 303,153 |
| End Cash Position | 138,295 | 150,662 | 203,519 | 231,733 | 261,076 |
| Net Cash Flow | $-65,224 | $-52,857 | $-99,634 | $-71,420 | $-42,077 |
| Free Cash Flow | |||||
| Operating Cash Flow | -81,648 | -50,739 | -119,563 | -91,495 | -64,543 |
| Capital Expenditure | -1,662 | -1,401 | -3,618 | -1,628 | -747 |
| Free Cash Flow | -83,310 | -52,140 | -123,181 | -93,123 | -65,290 |